Suppression of c-MET overcomes erlotinib resistance in tongue cancer cells

Keqiang Huang, Dongxu Liu Department of Orthodontics, School of Stomatology, Shandong University, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Jinan 250012, China Background: Erlotinib is a commonly used molecular-targeted drug for the treatment of tongue cancer. However, the de...

Full description

Bibliographic Details
Main Authors: Huang K, Liu D
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:OncoTargets and Therapy
Subjects:
Online Access:https://www.dovepress.com/suppression-of-c-met-overcomes-erlotinib-resistance-in-tongue-cancer-c-peer-reviewed-article-OTT

Similar Items